Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 172 is a predicted non-functional genomic sequence related to the 7SK small nuclear RNA gene (RN7SK), designated as a pseudogene because it does not encode an active small nuclear RNA and has no known biological or therapeutic role. In contrast, the functional 7SK RNA is a non-coding RNA that regulates gene transcription by sequestering and inactivating the positive transcription elongation factor b (P-TEFb)[1][2][3][4][5]. Dysregulation of 7SK RNA (not its pseudogenes) has been implicated in human disease, including cancer and heart disorders[2][4]. RN7SKP172 has no established role, function, or relevance as a drug target. If information for RN7SKP172 is sought for drug discovery or disease association, the canonical RN7SK gene and its product, 7SK snRNA, should be considered instead[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 172 (RN7SKP172).